Global Surface Disinfectant Market 2022 | Growth, Opportunities, Demand and Forecast to 2026

 The Global Surface Disinfectant Market is projected to reach USD 4.3 billion by 2026 from USD 2.9 billion in 2021, at a CAGR of 8.4%. Market growth is driven by stringent regulations for the use of surface disinfectants, increasing use of newer surface disinfectants for sanitization, and higher prevalence of HAIs.



Get Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=231286043

Key Market Players       

3M (US), Procter and Gamble (US), Reckitt Benckiser Group PLC (UK), Ecolab (US), Steris (US),  The Clorox Company (US), Diversey Holdings LTD. (US), Cantel Medical (US), CarrollCLEAN (US), PAUL HARTMANN AG (Germany), Metrex Research LLC (US), Whiteley (Australia), Medline Industries, Inc. (US), GOJO Industries, Inc. (US), Pharmax Pharmaceuticals FZ-LLC (Canada), PDI, Inc. (US), Becto, Inc. (US), GESCO Healthcare Pvt. Ltd. (India), MEDALKAN (Greece), Ruhof (US), Contec, Inc. (US), Cetylite Inc. (US), Micro-Scientific, LLC (US), Pal International (UK), Brulin Holding Company, Inc. (US).

COVID-19 Impact on Global Surface Disinfectant Industry

The pandemic has disrupted healthcare systems all over the world, with hospitals being overwhelmed due to the increasing influx of patients. Temporary hospitals are also being set up to deal with an increasing disease incidence. Hence, the spread of COVID-19 has spurred a surge in demand for cleaning and disinfection products due to the growing awareness about safety, hygiene, and health. Increasing healthcare expenditure in North America and an increase in the number of temporary hospitals are some of the major factors driving the demand and uptake of antiseptics and disinfectants

Factors such as the increasing demand for hospital beds and ICUs in North America, the rising proliferation of isolation facilities, and increasing awareness among consumers on hygiene and preventive healthcare have greatly boosted the demand for surface disinfectants.

“North America is the largest regional market for surface disinfectant market”

The global market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global . The North American market's growth can be attributed to the increase in prevalence of chronic diseases.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231286043

Market Dynamics

Driver: Rising number of stringent regulations for the use of surface disinfectants

The increase in number of stringent regulations focus on the development of suitable policies for housekeeping services, which puts a premium on good housekeeping and sanitation. Thus, due to such regulatory guidelines, there will be improvement in the regular usage of surface disinfectants across healthcare settings

Opportunity: Increasing healthcare expenditure and focus in emerging economies

Emerging economies, such as India, Brazil, and South Africa, provide significant opportunities for players in the sterilization and disinfection markets. Emerging economies in the APAC region present lucrative investment opportunities for multinational infection control companies to offshore their business operations to these markets.

Recent Developments

·         In November 2020, 3M (US) launched TB Quat Disinfectant Ready-to-Use Cleaner.

·         In June 2019, Reckitt Benckiser Group PLC (UK) received the EPA approval for its Lysol Disinfectant Spray and Lysol Disinfectant Max Cover Mist for surface disinfection and effective use against SARS-CoV-2.

·         In May 2020, Ecolab (US) acquired Holchem Group to strengthen its hygiene and cleaning products and services portfolio for the food & beverage, food service, and hospitality industries.

Comments

Post a Comment

Popular posts from this blog

Healthcare Simulation Market Size & Share - Global Future Growth Predictions

Image
 The global healthcare simulation market is projected to reach USD 4.6 billion by 2028 from USD 2.2 billion in 2023, at a high CAGR of 15.7% during the forecast period. The expansion of this market is fueled by the increasing adoption of advanced techniques and methodologies in delivering medical education, along with restricted patient access during medical training. Nevertheless, the market's growth is anticipated to be somewhat hampered by the constrained availability of funds and incomplete replication of medical simulators. Market Size Introduction: The healthcare simulation market size represents the total valuation of products and services within the healthcare simulation industry over a specific period, typically a year. It encompasses various simulation technologies, including manikins, simulators, simulated environments, and software solutions, utilized for medical training, education, and research purposes. Understanding the market size is crucial for stakeholders as ...
Read more

Global Dental Practice Management Software Industry worth $2.3 billion By 2028

Image
 The Global Dental Practice Management Software Market in terms of revenue was estimated to be worth $1.5 billion in 2023 and is poised to reach $2.3 billion in 2028, growing at a CAGR of 8.6% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The rising awareness of oral hygiene and dental treatment, the increasing demand for advanced dental procedures, and the growing market for dental tourism in developing countries are major key drivers for the market. However, data privacy and security issues are the factors which may slow down market growth. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153532396 Dental Practice Management Software Industry Dynamics Driver: Rising demand for advanced cosmetic dental procedures Cosmetic d...
Read more

Humanized Mouse and Rat Model Market worth $349 million by 2028

Image
  In the near future, the humanized mouse and rat model industry is set to undergo transformative advancements, revolutionizing biomedical research and drug development. These cutting-edge models, where mice and rats are genetically modified to possess human-like characteristics and immune systems, will play a pivotal role in bridging the gap between preclinical studies and clinical trials. Through refined genetic engineering techniques, these models will closely mimic human physiology, enabling more accurate and predictive assessments of drug safety, efficacy, and disease mechanisms. Moreover, the industry will witness the integration of advanced technologies, such as CRISPR/Cas9, to expedite the creation of customized humanized models, tailoring them to specific diseases or individual patient profiles. These advancements will spur collaboration between academia, pharmaceutical companies, and biotech firms, fostering a dynamic research ecosystem focused on targeted therapies and p...
Read more